Advances in AI Pharmaceuticals: Secret IPO Filer at HKEX

AI pharmaceuticals witness key market actions with yet another Hong Kong IPO applicant secretively emerging under Baidu’s support. The latest news indicates that Biomap, a life sciences AI big model company founded by Baidu under the lead of Li Yanhong, has discreetly submitted an IPO application to the HKEX, aiming to raise hundreds of millions of dollars. This preparation for Biomap’s IPO has been in the works for a while. Last June, CEO Liu Wei openly voiced plans for a Hong Kong listing within a year and a half, highlighting it as an ideal market for early-stage tech firms. Earlier…